Government announces help for those with COPD buying inhalers

    Wednesday, 19 June 2024 07:00

    By Tonya Organ

    The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place.

    Government is expanding prescription coverage for long-acting muscarinic antagonist (LAMAs) inhalers, used in the treatment of Chronic Obstructive Pulmonary Disease. The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place. This will ensure NLPDP beneficiaries have timely access to these inhalers for the treatment of their COPD.

     

     

    To report an error, submit a news tip, or provide feedback, please e-mail news@bayfm.ca or call (709) 637-0183.

    More from Local News

     

     

     

    BayFM recognizes support from the following agencies:

                        

    Today's Weather

    • Corner Brook

      Sleet

      High: 6°C | Low: 2°C

    • Deer Lake

      Heavy Rain

      High: 6°C | Low: 1°C

    • Stephenville

      Heavy Rain

      High: 6°C | Low: 3°C

    Recently Played

    Podcasts

    • The Plain Truth

      The Plain Truth, Wednesday November 13, 2025

      Host Paula Sheppard's guest this week is Peter Parsons, Inter-Agency Coordinator with the Community Mental Health Initiative

    • BayFM On-Demand

      Trash Talk Thursday , November 13, 2025

      Lots of uptick on the new app

    • Sunday Night Geek

      Sunday Night Geek, November 9, 2025

      Sunday Night Geek, November 9, 2025